Sagespring Wealth Partners’s Gilead Sciences GILD Stock Holding History

Sagespring Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.76M	Sell	21,878 -2,189	-9%	-$288K	0.04%	183
2026 Q1	$3.35M	Buy	24,067 +1,122	+5%	+$157K	0.06%	147
2025 Q4	$2.82M	Buy	22,945 +3,555	+18%	+$432K	0.05%	159
2025 Q3	$2.15M	Buy	19,390 +2,039	+12%	+$232K	0.04%	173
2025 Q2	$1.92M	Buy	17,351 +3,848	+28%	+$410K	0.04%	176
2025 Q1	$1.51M	Buy	13,503 +1,563	+13%	+$161K	0.04%	191
2024 Q4	$1.1M	Buy	+11,940	New	+$1.08M	0.03%	203

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sagespring Wealth Partners's GILD Position: Q2 2026 in Review

Sagespring Wealth Partners reduced its Gilead Sciences (GILD) stake by 9.1% in Q2 2026, selling an estimated $288K and leaving 21,878 shares worth $2.76M. The position accounts for 0.04% of the portfolio, ranked #183.

Sagespring Wealth Partners first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.35M in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Sagespring Wealth Partners held 21,878 shares of Gilead Sciences worth $2.76M as of Q2 2026.
Sagespring Wealth Partners sold 2,189 Gilead Sciences shares in Q2 2026, an estimated $288K.
Gilead Sciences made up 0.04% of Sagespring Wealth Partners's portfolio in Q2 2026, its #183 holding.
Sagespring Wealth Partners first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
Sagespring Wealth Partners's Gilead Sciences position peaked at $3.35M in Q1 2026.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.